The manufacturing alliance is expected to allow ISP and Vivimed to jointly market specific products used in sprays and lotions that include UVA and UVB protective properties.
Under the agreement, beginning October 1, 2010, ISP will add UVA and UVB absorbers manufactured by Vivimed Labs to its portfolio of sun protection products, with full support given to these by ISP’s global sales, marketing and technical service teams.
In a filing to the BSE Vivimed said: “In turn, Vivimed will benefit from tapping into ISP’s global sales, marketing and technical service team, extending ISP’s distribution worldwide for a product portfolio of more than 500 chemicals.”
Robert Frick, SVP of supply chain at ISP, said: “The manufacturing alliance with Vivimed Labs is beneficial for ISP because it provides us with the capability to improve our sunscreen value offering in the marketplace.
“Working alongside Vivimed, we are better positioned to supply long-established sunscreen technologies to customers, and at the same time, produce ample supplies of our flagship technologies marketed under the Escalol trade name. ISP looks forward to working with Vivimed Labs.”